French Pharma Stock News

ENXTPA:LSS
ENXTPA:LSSSoftware

3 European Stocks Estimated To Be Trading At Discounts Of Up To 47.6%

As the pan-European STOXX Europe 600 Index edges closer to record highs, buoyed by optimism around future earnings and economic prospects, investors are increasingly on the lookout for opportunities that may be trading below their intrinsic value. In this context, identifying undervalued stocks becomes crucial, as they offer potential for growth amid a cautiously optimistic market environment where strategic selection based on fundamentals can lead to rewarding outcomes.
ENXTPA:MAU
ENXTPA:MAUOil and Gas

European Dividend Stocks To Consider Now

As the pan-European STOXX Europe 600 Index hovers near record highs, buoyed by optimism about future earnings and economic prospects, investors are increasingly focused on opportunities within the region's dividend stocks. In this context, selecting a robust dividend stock involves considering factors such as stable cash flows and strong balance sheets, which can provide resilience amid fluctuating market sentiments.
ENXTPA:SPIE
ENXTPA:SPIECommercial Services

Should SPIE’s New Tesla Megapack Framework Shape Strategy for (ENXTPA:SPIE) Energy Transition Investors?

SPIE recently announced that it has signed a renewable three‑year European framework agreement with Tesla to deliver Megapack-based battery energy storage system projects across its specialist subsidiaries, covering existing and potential work in France, Belgium, the Netherlands, Poland and Germany. This deal not only deepens SPIE’s role in the energy transition by integrating large-scale storage into power grids, it also standardises project execution and legal terms across Europe,...
ENXTPA:BB
ENXTPA:BBCommercial Services

Will Exiting Rocketbook and Tattoo Brands Refocus Société BIC's (ENXTPA:BB) Narrative on Core Staples?

In December 2025, Société BIC said it would discontinue Rocketbook and its Skin Creative tattoo businesses Inkbox and Tattly, winding down their operations by the first quarter of 2026 after reviewing their performance against group ambitions. This exit from digital writing and tattoo products marks a clear refocus on BIC’s core categories and a tightening of its portfolio discipline. We’ll now examine how BIC’s decision to exit Rocketbook and Skin Creative-tattoo activities reshapes its...